Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Explore the Effects of Probiotics on Endotoxin Levels in Type 2 Diabetes Mellitus Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Warwick Medical School
Winclove Bio Industries BV
Information provided by (Responsible Party):
Nasser Al-Daghri, King Saud University
ClinicalTrials.gov Identifier:
NCT01765517
First received: January 1, 2013
Last updated: August 29, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):